Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,809 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03556566 | Open Label Immunotherapy Trial for Ovarian Cancer(V3-OVA) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT04068766 | Efficacy of Paracervical Block in Laparoscopic Myomectomy: a Randomized Controlled Trial (PALM)(PALM) | unknown | N/A | 62 | Kangbuk Samsung HospitalOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases(CORE) | unknown | Phase 2 / Phase 3 | 245 | Royal Marsden NHS Foundation TrustOTHER | 2 | Aug 21, 2019 | clinicaltrials |
| NCT01682772 | TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer(TOPARP) | unknown | Phase 2 | 148 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT03595722 | Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers | unknown | N/A | 60 | Imperial College LondonOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT04055038 | Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)(EPITOC) | unknown | Phase 2 / Phase 3 | 164 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT03451812 | Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer(PCAPETMR) | unknown | — | 120 | Chang Gung Memorial HospitalOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02873013 | Asia Study Group of Prostate Cancer (A-CaP Study) | unknown | — | 20,000 | Japan Study Group of Prostate CancerOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04001023 | Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia(OVANOX) | unknown | N/A | 40 | Turku University HospitalOTHER_GOV | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04046185 | Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer(ECCT) | unknown | Early Phase 1 | 60 | Shanghai First Maternity and Infant HospitalOTHER | 0 | Aug 6, 2019 | clinicaltrials |
| NCT00806117 | Comparison of Different Subsequent Treatments After Radical Surgery(STARS) | unknown | Phase 3 | 1,080 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2019 | clinicaltrials |
| NCT04037488 | Changes in Body Composition With Patients Under Androgen Deprivation Therapy | unknown | — | 56 | Seoul National University HospitalOTHER | 1 | Jul 30, 2019 | clinicaltrials |
| NCT02225262 | A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | unknown | N/A | 100 | Community Cancer Center, Normal, IllinoisOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT04031378 | Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer | unknown | Phase 2 | 100 | Fundacao ChampalimaudOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT04029909 | A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | unknown | Phase 1 | 12 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Jul 23, 2019 | clinicaltrials |
| NCT01267851 | Clinical Database and Biobank of Patients With Gynecologic Neoplasms | unknown | — | 1,600,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT04022148 | The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years | unknown | — | 2,800 | University of FukuiOTHER | 0 | Jul 19, 2019 | clinicaltrials |
| NCT04010487 | Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis | unknown | — | 40 | Lei LiOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02334579 | Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | unknown | N/A | 146 | Swedish Medical CenterOTHER | 1 | Jul 12, 2019 | clinicaltrials |
| NCT03448354 | Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer | unknown | N/A | 204 | Ajou University School of MedicineOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT04004858 | Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)(PROTRACT) | unknown | N/A | 50 | Southlake HealthOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT03255135 | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | unknown | N/A | 130 | Hospital de Transplante Doutor Euryclides de Jesus ZerbiniOTHER | 1 | Jun 27, 2019 | clinicaltrials |
| NCT03885505 | An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 0 | Jun 25, 2019 | clinicaltrials |
| NCT03996993 | Defining Recurrent Disease With Axumin™ | unknown | — | 20 | Cancer Center of IrvineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT00511641 | Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer | unknown | — | 1,342 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 24, 2019 | clinicaltrials |
| NCT03963882 | NAC Followed by RH for the Treatment of LACC | unknown | Phase 2 | 60 | Lei LiOTHER | 1 | Jun 20, 2019 | clinicaltrials |
| NCT03967457 | Comprehensive Study on the Quality of Life in Cervical Cancer Patients | unknown | — | 10,000 | Lei LiOTHER | 1 | Jun 20, 2019 | clinicaltrials |
| NCT03987737 | Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate(GAS) | unknown | N/A | 46 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Jun 17, 2019 | clinicaltrials |
| NCT03982706 | Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy | unknown | — | 1,000 | Rabin Medical CenterOTHER | 0 | Jun 13, 2019 | clinicaltrials |
| NCT03979573 | Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer(PROMM-AS) | unknown | N/A | 90 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jun 7, 2019 | clinicaltrials |
| NCT03972722 | Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer(CC) | unknown | Phase 2 | 89 | Guangzhou Gloria Biosciences Co., Ltd.INDUSTRY | 1 | Jun 5, 2019 | clinicaltrials |
| NCT03975127 | Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme? | unknown | N/A | 50,000 | NHS Greater Glasgow and ClydeOTHER | 0 | Jun 5, 2019 | clinicaltrials |
| NCT03966456 | Real World Study of Four PD-1 Agents in China | unknown | — | 500 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT03960788 | Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | unknown | Early Phase 1 | 50 | University of CincinnatiOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT01311856 | Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors | unknown | — | 60 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00850941 | Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | unknown | — | 146 | M.D. Anderson Cancer CenterOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT03942068 | Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 35 | Henan Cancer HospitalOTHER_GOV | 0 | May 8, 2019 | clinicaltrials |
| NCT00573586 | Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada | unknown | N/A | 20 | SonaCare MedicalINDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03630926 | Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.(VPAC) | unknown | — | 45 | Intermountain Health Care, Inc.OTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03924882 | Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 23, 2019 | clinicaltrials |
| NCT03489473 | FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment(FESPET) | unknown | — | 40 | Radboud University Medical CenterOTHER | 0 | Apr 18, 2019 | clinicaltrials |
| NCT02349958 | Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy(HIPEC/IPHC) | unknown | Phase 2 | 200 | Bay Area Gynecology OncologyOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02861209 | Collaborative Network to Take Responsibility for Oral Anticancer Therapy(CONTACT) | unknown | N/A | 228 | KU LeuvenOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03916679 | MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer | unknown | Phase 1 / Phase 2 | 20 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT00770822 | Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer(SetPace) | unknown | N/A | 466 | SonaCare MedicalINDUSTRY | 1 | Apr 10, 2019 | clinicaltrials |
| NCT00772317 | A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)(STAR) | unknown | N/A | 117 | SonaCare MedicalINDUSTRY | 2 | Apr 10, 2019 | clinicaltrials |
| NCT03799913 | MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | unknown | Early Phase 1 | 20 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Aug 30, 2019source: clinicaltrials